HEPA insider filings
Hepion Pharmaceuticals, Inc. — 28 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-02. Screen HEPA transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 15 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 6 filings by 6 insiders — 16,700,000 shares, $835,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: purchase of 8,000,000 shares @ $0.05 ($400,000) by LoPriore Vincent S, filed 2026-08-12.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| LoPriore Vincent S — Executive Chairman, Director | 3 | 2 legs · 10,000,000 sh · $500,000 | — | 4 |
| Appajosyula Sireesh — Chief Operating Officer, Director | 2 | 1 leg · 2,000,000 sh · $100,000 | — | 2 |
| Purcell Michael J. — Director | 2 | 1 leg · 2,000,000 sh · $100,000 | — | 2 |
| Stetz Gary S. — Interim CEO, Director | 2 | 1 leg · 2,000,000 sh · $100,000 | — | 2 |
| Stetz Gary S. II — Director | 2 | 1 leg · 500,000 sh · $25,000 | — | 2 |
| Fisher Danina — Director | 2 | 1 leg · 200,000 sh · $10,000 | — | 2 |
| Liddy James Gordon — Director | 1 | — | — | 1 |
| LoPriore Chase — VP, Corp. Dev., Director | 1 | — | — | 1 |
Recent insider filings — Hepion Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | Fisher Danina — Director | Purchase (P): 200,000 @ $0.05 · Purchase (P): 200,000 (derivative) @ $0 | EDGAR |
| 2026-09-14 | 4 | LoPriore Vincent S — Executive Chairman, Director | Purchase (P): 12,500,000 (derivative) @ $0 | EDGAR |
| 2026-09-10 | 4 | Purcell Michael J. — Director | Grant/award (A): 299,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | LoPriore Chase — VP, Corp. Dev., Director | Grant/award (A): 1,345,500 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | LoPriore Vincent S — Executive Chairman, Director | Grant/award (A): 1,345,500 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Stetz Gary S. — Interim CEO, Director | Grant/award (A): 1,345,500 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Fisher Danina — Director | Grant/award (A): 299,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Stetz Gary S. II — Director | Grant/award (A): 299,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Appajosyula Sireesh — Chief Operating Officer, Director | Grant/award (A): 1,345,500 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Liddy James Gordon — Director | Grant/award (A): 299,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Stetz Gary S. II — Director | Purchase (P): 500,000 @ $0.05 · Purchase (P): 500,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Purcell Michael J. — Director | Purchase (P): 2,000,000 @ $0.05 · Purchase (P): 2,000,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Stetz Gary S. — Interim CEO, Director | Purchase (P): 2,000,000 @ $0.05 · Purchase (P): 2,000,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | LoPriore Vincent S — Executive Chairman, Director | Purchase (P): 8,000,000 @ $0.05 · Purchase (P): 2,000,000 @ $0.05 · Purchase (P): 8,000,000 (derivative) @ $0 · Purchase (P): 2,000,000 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Appajosyula Sireesh — Chief Operating Officer, Director | Purchase (P): 2,000,000 @ $0.05 · Purchase (P): 2,000,000 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Purcell Michael J. — Director | Purchase (P): 1,250,000 @ $0.04 | EDGAR |
| 2026-04-27 | 4 | LoPriore Vincent S — Executive Chairman, Director, 10% owner | Purchase (P): 5,000,000 @ $0.04 · Purchase (P): 1,250,000 @ $0.04 | EDGAR |
| 2026-04-27 | 4 | Appajosyula Sireesh — Director | Purchase (P): 1,250,000 @ $0.04 | EDGAR |
| 2026-04-27 | 4 | Stetz Gary S. — Interim CEO, Director | Purchase (P): 1,250,000 @ $0.04 | EDGAR |
| 2024-03-07 | 4 | Purcell Michael J. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Block Timothy M. — Director | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Lbiati Kaouthar — Director | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | BRANCACCIO JOHN P — Chairman, Director | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | JACOB GARY S — Director | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2023-11-28 | 4 | Wijngaard Peter — Director | Purchase (P): 2,500 @ $3.09 · Purchase (P): 2,500 @ $3.05 | EDGAR |
| 2023-09-20 | 4 | Wijngaard Peter — Director | Purchase (P): 1,000 @ $5.82 · Purchase (P): 139 @ $5.45 · Purchase (P): 861 @ $5.37 · Purchase (P): 1,000 @ $5.64 | EDGAR |
| 2023-09-19 | 4 | Foster Robert T — CEO and Director, Director | Purchase (P): 1,600 @ $5.60 | EDGAR |
| 2023-09-18 | 4 | Foster Robert T — CEO,CSO and Director, Director | Purchase (P): 1,600 @ $5.40 | EDGAR |
Recent 8-K events — Hepion Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-02 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-28 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HEPA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →